Tokyo Tape
Sign in
← Takeda Pharmaceutical

Annual report

4502.TEDINET S100R3K7
Period2022-04-01 → 2023-03-31
Filed2023-06-28
StandardIFRS
ConsolidatedYes
Data checks21 of 21 passed
Key figures · 157
MetricValuePeriodScopeSource row
Revenue¥4.03T2022-04-01 → 2023-03-31Cons.Revenue IFRS
Revenue¥3.57T2021-04-01 → 2022-03-31Cons.Revenue IFRS
Revenue¥3.20T2020-04-01 → 2021-03-31dCons.Revenue IFRS (5-year summary)
Revenue¥3.29T2019-04-01 → 2020-03-31dCons.Revenue IFRS (5-year summary)
Revenue¥2.10T2018-04-01 → 2019-03-31dCons.Revenue IFRS (5-year summary)
Operating income¥490.5bn2022-04-01 → 2023-03-31Cons.Operating profit loss IFRS
Operating income¥460.8bn2021-04-01 → 2022-03-31Cons.Operating profit loss IFRS
Profit before tax¥375.1bn2022-04-01 → 2023-03-31Cons.Profit loss before tax IFRS
Profit before tax¥302.6bn2021-04-01 → 2022-03-31Cons.Profit loss before tax IFRS
Profit before tax¥366.2bn2020-04-01 → 2021-03-31dCons.Profit loss before tax IFRS (5-year summary)
Profit before tax−¥60.8bn2019-04-01 → 2020-03-31dCons.Profit loss before tax IFRS (5-year summary)
Profit before tax¥127.6bn2018-04-01 → 2019-03-31dCons.Profit loss before tax IFRS (5-year summary)
Net income (owners)¥317.0bn2022-04-01 → 2023-03-31Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥230.1bn2021-04-01 → 2022-03-31Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥376.0bn2020-04-01 → 2021-03-31dCons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income (owners)¥44.2bn2019-04-01 → 2020-03-31dCons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income (owners)¥135.2bn2018-04-01 → 2019-03-31dCons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income¥317.0bn2022-04-01 → 2023-03-31Cons.Profit loss IFRS
Net income¥230.2bn2021-04-01 → 2022-03-31Cons.Profit loss IFRS
Net income¥376.2bn2020-04-01 → 2021-03-31dCons.Profit loss IFRS (5-year summary)
Net income¥44.3bn2019-04-01 → 2020-03-31dCons.Profit loss IFRS (5-year summary)
Net income¥135.1bn2018-04-01 → 2019-03-31dCons.Profit loss IFRS (5-year summary)
Total assets¥13.96Tat 2023-03-31Cons.Assets IFRS
Total assets¥13.18Tat 2022-03-31Cons.Assets IFRS
Total assets¥12.91Tat 2021-03-31dCons.Total assets IFRS (5-year summary)
Total assets¥12.82Tat 2020-03-31dCons.Total assets IFRS (5-year summary)
Total assets¥13.79Tat 2019-03-31dCons.Total assets IFRS (5-year summary)
Total liabilities¥7.60Tat 2023-03-31Cons.Liabilities IFRS
Total liabilities¥7.49Tat 2022-03-31Cons.Liabilities IFRS
Net assets / equity¥6.35Tat 2023-03-31Cons.Equity IFRS
Net assets / equity¥5.68Tat 2022-03-31Cons.Equity IFRS
Net assets / equity¥5.18Tat 2021-03-31dCons.Equity IFRS
Equity (owners)¥6.35Tat 2023-03-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥5.68Tat 2022-03-31Cons.Equity attributable to owners of parent IFRS
Cash & equivalents¥533.5bnat 2023-03-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥849.7bnat 2022-03-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥966.2bnat 2021-03-31dCons.Cash and cash equivalents IFRS
Cash & equivalents¥637.6bnat 2020-03-31dCons.Cash and cash equivalents IFRS (5-year summary)
Cash & equivalents¥702.1bnat 2019-03-31dCons.Cash and cash equivalents IFRS (5-year summary)
Operating cash flow¥977.2bn2022-04-01 → 2023-03-31Cons.Net cash provided by used in operating activities IFRS
Operating cash flow¥1.12T2021-04-01 → 2022-03-31Cons.Net cash provided by used in operating activities IFRS
Operating cash flow¥1.01T2020-04-01 → 2021-03-31dCons.Cash flows from used in operating activities IFRS (5-year summary)
Operating cash flow¥669.8bn2019-04-01 → 2020-03-31dCons.Cash flows from used in operating activities IFRS (5-year summary)
Operating cash flow¥328.5bn2018-04-01 → 2019-03-31dCons.Cash flows from used in operating activities IFRS (5-year summary)
Investing cash flow−¥607.1bn2022-04-01 → 2023-03-31Cons.Net cash provided by used in investing activities IFRS
Investing cash flow−¥198.1bn2021-04-01 → 2022-03-31Cons.Net cash provided by used in investing activities IFRS
Investing cash flow¥393.5bn2020-04-01 → 2021-03-31dCons.Cash flows from used in investing activities IFRS (5-year summary)
Investing cash flow¥292.1bn2019-04-01 → 2020-03-31dCons.Cash flows from used in investing activities IFRS (5-year summary)
Investing cash flow−¥2.84T2018-04-01 → 2019-03-31dCons.Cash flows from used in investing activities IFRS (5-year summary)
Financing cash flow−¥709.1bn2022-04-01 → 2023-03-31Cons.Net cash provided by used in financing activities IFRS
Financing cash flow−¥1.07T2021-04-01 → 2022-03-31Cons.Net cash provided by used in financing activities IFRS
Financing cash flow−¥1.09T2020-04-01 → 2021-03-31dCons.Cash flows from used in financing activities IFRS (5-year summary)
Financing cash flow−¥1.01T2019-04-01 → 2020-03-31dCons.Cash flows from used in financing activities IFRS (5-year summary)
Financing cash flow¥2.95T2018-04-01 → 2019-03-31dCons.Cash flows from used in financing activities IFRS (5-year summary)
EPS (basic)¥204.292022-04-01 → 2023-03-31Cons.Basic earnings loss per share IFRS
EPS (basic)¥147.142021-04-01 → 2022-03-31Cons.Basic earnings loss per share IFRS
EPS (basic)¥240.722020-04-01 → 2021-03-31dCons.Basic earnings loss per share IFRS (5-year summary)
EPS (basic)¥28.412019-04-01 → 2020-03-31dCons.Basic earnings loss per share IFRS (5-year summary)
EPS (basic)¥140.612018-04-01 → 2019-03-31dCons.Basic earnings loss per share IFRS (5-year summary)
EPS (diluted)¥201.942022-04-01 → 2023-03-31Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥145.872021-04-01 → 2022-03-31Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥238.962020-04-01 → 2021-03-31dCons.Diluted earnings loss per share IFRS (5-year summary)
EPS (diluted)¥28.252019-04-01 → 2020-03-31dCons.Diluted earnings loss per share IFRS (5-year summary)
EPS (diluted)¥139.822018-04-01 → 2019-03-31dCons.Diluted earnings loss per share IFRS (5-year summary)
Net assets per share¥4,087.49at 2023-03-31Cons.Equity to asset ratio IFRS (5-year summary)
Net assets per share¥3,665.61at 2022-03-31Cons.Equity to asset ratio IFRS (5-year summary)
Net assets per share¥3,308.93at 2021-03-31dCons.Equity to asset ratio IFRS (5-year summary)
Net assets per share¥3,032.22at 2020-03-31dCons.Equity to asset ratio IFRS (5-year summary)
Net assets per share¥3,332.94at 2019-03-31dCons.Equity to asset ratio IFRS (5-year summary)
Equity ratio45.5%at 2023-03-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio43.1%at 2022-03-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio40.1%at 2021-03-31dCons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio36.8%at 2020-03-31dCons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio37.6%at 2019-03-31dCons.Ratio of owners equity to gross assets IFRS (5-year summary)
ROE5.3%2022-04-01 → 2023-03-31Cons.Rate of return on equity IFRS (5-year summary)
ROE4.2%2021-04-01 → 2022-03-31Cons.Rate of return on equity IFRS (5-year summary)
ROE7.6%2020-04-01 → 2021-03-31dCons.Rate of return on equity IFRS (5-year summary)
ROE0.9%2019-04-01 → 2020-03-31dCons.Rate of return on equity IFRS (5-year summary)
ROE3.8%2018-04-01 → 2019-03-31dCons.Rate of return on equity IFRS (5-year summary)
Employees49,095at 2023-03-31Cons.Number of employees
Employees47,347at 2022-03-31Cons.Number of employees
Employees47,099at 2021-03-31dCons.Number of employees
Employees47,495at 2020-03-31dCons.Number of employees
Employees49,578at 2019-03-31dCons.Number of employees
Revenue¥632.1bn2022-04-01 → 2023-03-31StandaloneNet sales
Revenue¥764.3bn2021-04-01 → 2022-03-31StandaloneNet sales
Revenue¥602.6bn2020-04-01 → 2021-03-31dStandaloneNet sales (5-year summary)
Revenue¥616.3bn2019-04-01 → 2020-03-31dStandaloneNet sales (5-year summary)
Revenue¥651.3bn2018-04-01 → 2019-03-31dStandaloneNet sales (5-year summary)
Operating income¥136.1bn2022-04-01 → 2023-03-31StandaloneOperating income
Operating income¥293.7bn2021-04-01 → 2022-03-31StandaloneOperating income
Ordinary income¥340.1bn2022-04-01 → 2023-03-31StandaloneOrdinary income
Ordinary income¥550.9bn2021-04-01 → 2022-03-31StandaloneOrdinary income
Ordinary income¥50.0bn2020-04-01 → 2021-03-31dStandaloneOrdinary income loss (5-year summary)
Ordinary income¥72.3bn2019-04-01 → 2020-03-31dStandaloneOrdinary income loss (5-year summary)
Ordinary income¥17.5bn2018-04-01 → 2019-03-31dStandaloneOrdinary income loss (5-year summary)
Profit before tax¥383.0bn2022-04-01 → 2023-03-31StandaloneIncome before income taxes
Profit before tax¥371.9bn2021-04-01 → 2022-03-31StandaloneIncome before income taxes
Net income¥330.6bn2022-04-01 → 2023-03-31StandaloneProfit loss
Net income¥324.4bn2021-04-01 → 2022-03-31StandaloneProfit loss
Net income¥247.5bn2020-04-01 → 2021-03-31dStandaloneNet income loss (5-year summary)
Net income¥130.6bn2019-04-01 → 2020-03-31dStandaloneNet income loss (5-year summary)
Net income¥88.2bn2018-04-01 → 2019-03-31dStandaloneNet income loss (5-year summary)
Total assets¥9.41Tat 2023-03-31StandaloneAssets
Total assets¥9.64Tat 2022-03-31StandaloneAssets
Total assets¥10.86Tat 2021-03-31dStandaloneTotal assets (5-year summary)
Total assets¥10.29Tat 2020-03-31dStandaloneTotal assets (5-year summary)
Total assets¥9.53Tat 2019-03-31dStandaloneTotal assets (5-year summary)
Total liabilities¥5.20Tat 2023-03-31StandaloneLiabilities
Total liabilities¥5.35Tat 2022-03-31StandaloneLiabilities
Net assets / equity¥4.21Tat 2023-03-31StandaloneNet assets
Net assets / equity¥4.29Tat 2022-03-31StandaloneNet assets
Net assets / equity¥4.43Tat 2021-03-31dStandaloneNet assets
Net assets / equity¥4.55Tat 2020-03-31dStandaloneNet assets (5-year summary)
Net assets / equity¥4.65Tat 2019-03-31dStandaloneNet assets (5-year summary)
Cash and deposits¥164.9bnat 2023-03-31StandaloneCash and deposits
Cash and deposits¥287.1bnat 2022-03-31StandaloneCash and deposits
EPS (basic)¥213.062022-04-01 → 2023-03-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥207.52021-04-01 → 2022-03-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥158.452020-04-01 → 2021-03-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥83.882019-04-01 → 2020-03-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥91.762018-04-01 → 2019-03-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (diluted)¥213.052022-04-01 → 2023-03-31StandaloneDiluted earnings per share (5-year summary)
EPS (diluted)¥207.52021-04-01 → 2022-03-31StandaloneDiluted earnings per share (5-year summary)
EPS (diluted)¥158.442020-04-01 → 2021-03-31dStandaloneDiluted earnings per share (5-year summary)
EPS (diluted)¥83.872019-04-01 → 2020-03-31dStandaloneDiluted earnings per share (5-year summary)
EPS (diluted)¥91.722018-04-01 → 2019-03-31dStandaloneDiluted earnings per share (5-year summary)
Dividend per share¥1802022-04-01 → 2023-03-31StandaloneDividend paid per share (5-year summary)
Dividend per share¥1802021-04-01 → 2022-03-31StandaloneDividend paid per share (5-year summary)
Dividend per share¥1802020-04-01 → 2021-03-31dStandaloneDividend paid per share (5-year summary)
Dividend per share¥1802019-04-01 → 2020-03-31dStandaloneDividend paid per share (5-year summary)
Dividend per share¥1802018-04-01 → 2019-03-31dStandaloneDividend paid per share (5-year summary)
Net assets per share¥2,704.87at 2023-03-31StandaloneNet assets per share (5-year summary)
Net assets per share¥2,769.31at 2022-03-31StandaloneNet assets per share (5-year summary)
Net assets per share¥2,835.81at 2021-03-31dStandaloneNet assets per share (5-year summary)
Net assets per share¥2,919.21at 2020-03-31dStandaloneNet assets per share (5-year summary)
Net assets per share¥2,987.94at 2019-03-31dStandaloneNet assets per share (5-year summary)
Equity ratio44.7%at 2023-03-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio44.5%at 2022-03-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio40.8%at 2021-03-31dStandaloneEquity to asset ratio (5-year summary)
Equity ratio44.2%at 2020-03-31dStandaloneEquity to asset ratio (5-year summary)
Equity ratio48.7%at 2019-03-31dStandaloneEquity to asset ratio (5-year summary)
ROE7.8%2022-04-01 → 2023-03-31StandaloneRate of return on equity (5-year summary)
ROE7.4%2021-04-01 → 2022-03-31StandaloneRate of return on equity (5-year summary)
ROE5.5%2020-04-01 → 2021-03-31dStandaloneRate of return on equity (5-year summary)
ROE2.8%2019-04-01 → 2020-03-31dStandaloneRate of return on equity (5-year summary)
ROE2.8%2018-04-01 → 2019-03-31dStandaloneRate of return on equity (5-year summary)
Shares issued1,582,296,000at 2023-03-31StandaloneTotal number of issued shares (5-year summary)
Shares issued1,582,253,000at 2022-03-31StandaloneTotal number of issued shares (5-year summary)
Shares issued1,576,388,000at 2021-03-31dStandaloneTotal number of issued shares (5-year summary)
Shares issued1,576,374,000at 2020-03-31dStandaloneTotal number of issued shares (5-year summary)
Shares issued1,565,006,000at 2019-03-31dStandaloneTotal number of issued shares (5-year summary)
Employees5,486at 2023-03-31StandaloneNumber of employees
Employees5,149at 2022-03-31StandaloneNumber of employees
Employees4,966at 2021-03-31dStandaloneNumber of employees
Employees5,350at 2020-03-31dStandaloneNumber of employees
Employees5,291at 2019-03-31dStandaloneNumber of employees

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 2
SegmentItemPeriodValue
Pharmaceutical Businessreportable segmentemployeesat 2023-03-3149095 pure
Pharmaceutical Businessreportable segmentemployeesat 2023-03-315486 pure

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 1,742
ItemContextValueUnit
Total shareholder returnPrior4YearInstant_NonConsolidatedMember0.907
Total shareholder returnPrior3YearInstant_NonConsolidatedMember0.708
Total shareholder returnPrior2YearInstant_NonConsolidatedMember0.873
Total shareholder returnPrior1YearInstant_NonConsolidatedMember0.814
Total shareholder returnCurrentYearInstant_NonConsolidatedMember1.013
Total return on share price indexPrior4YearInstant_NonConsolidatedMember0.950
Total return on share price indexPrior3YearInstant_NonConsolidatedMember0.859
Total return on share price indexPrior2YearInstant_NonConsolidatedMember1.221
Total return on share price indexPrior1YearInstant_NonConsolidatedMember1.246
Total return on share price indexCurrentYearInstant_NonConsolidatedMember1.318
Number of employeesCurrentYearInstant_jpcrp030000-asr_E00919-000PharmaceuticalBusinessReportableSegmentMember49095
Number of employeesCurrentYearInstant49095
Number of employeesCurrentYearInstant_NonConsolidatedMember5486
Average age years information about reporting company information about employeesCurrentYearInstant_NonConsolidatedMember42.8
Average length of service years information about reporting company information about employeesCurrentYearInstant_NonConsolidatedMember14.0
Average annual salary information about reporting company information about employeesCurrentYearInstant_NonConsolidatedMember10972000JPY
Number of employeesCurrentYearInstant_NonConsolidatedMember_jpcrp030000-asr_E00919-000PharmaceuticalBusinessReportableSegmentMember5486
Number of employeesCurrentYearInstant_NonConsolidatedMember5486
Research and development expenses research and development activitiesCurrentYearDuration633300000000JPY
Capital expenditures overview of capital expenditures etcCurrentYearDuration185200000000JPY
Number of issued shares as of fiscal year end issued shares total number of shares etcFilingDateInstant_OrdinaryShareMember1582296025
Number of issued shares as of filing date issued shares total number of shares etcFilingDateInstant_OrdinaryShareMember1582324825
Number of issued shares as of fiscal year end issued shares total number of shares etcFilingDateInstant1582296025
Number of issued shares as of filing date issued shares total number of shares etcFilingDateInstant1582324825
Number of shares constituting one unitCurrentYearInstant_OrdinaryShareMember100
Number of shareholders national and local governmentsCurrentYearInstant_OrdinaryShareMember1
Number of shareholders financial institutionsCurrentYearInstant_OrdinaryShareMember266
Number of shareholders financial service providersCurrentYearInstant_OrdinaryShareMember58
Number of shareholders other corporationsCurrentYearInstant_OrdinaryShareMember3281
Number of shareholders foreign investors other than individualsCurrentYearInstant_OrdinaryShareMember1112
Number of shareholders foreign individual investorsCurrentYearInstant_OrdinaryShareMember761
Number of shareholders individuals and othersCurrentYearInstant_OrdinaryShareMember540329
Number of shareholders totalCurrentYearInstant_OrdinaryShareMember545808
Number of shares held number of units national and local governmentsCurrentYearInstant_OrdinaryShareMember4
Number of shares held number of units financial institutionsCurrentYearInstant_OrdinaryShareMember4435017
Number of shares held number of units financial service providersCurrentYearInstant_OrdinaryShareMember952185
Number of shares held number of units other corporationsCurrentYearInstant_OrdinaryShareMember484250
Number of shares held number of units foreign investors other than individualsCurrentYearInstant_OrdinaryShareMember6017950
Number of shares held number of units foreign individual investorsCurrentYearInstant_OrdinaryShareMember7514
Number of shares held number of units individuals and othersCurrentYearInstant_OrdinaryShareMember3912573
Number of shares held number of units totalCurrentYearInstant_OrdinaryShareMember15809493
Number of shares held shares less than one unitCurrentYearInstant_OrdinaryShareMember1346725
Percentage of shareholdings national and local governmentsCurrentYearInstant_OrdinaryShareMember0.0000
Percentage of shareholdings financial institutionsCurrentYearInstant_OrdinaryShareMember0.2805
Percentage of shareholdings financial service providersCurrentYearInstant_OrdinaryShareMember0.0602
Percentage of shareholdings other corporationsCurrentYearInstant_OrdinaryShareMember0.0306
Percentage of shareholdings foreigners other than individualsCurrentYearInstant_OrdinaryShareMember0.3807
Percentage of shareholdings foreign individualsCurrentYearInstant_OrdinaryShareMember0.0005
Percentage of shareholdings individuals and othersCurrentYearInstant_OrdinaryShareMember0.2475
Number of shares heldCurrentYearInstant_No1MajorShareholdersMember261558000

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 21 of 21 passed
balance sheet identityconsolidated 2022-03-31pass
balance sheet identityconsolidated 2023-03-31pass
balance sheet identitynon_consolidated 2022-03-31pass
balance sheet identitynon_consolidated 2023-03-31pass
dei present pass
period resolution pass
statement vs summary · net assetsnon_consolidated 2021-03-31pass
statement vs summary · net assetsnon_consolidated 2022-03-31pass
statement vs summary · net assetsnon_consolidated 2023-03-31pass
statement vs summary · net income attributable to parentconsolidated 2021-04-01/2022-03-31pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2023-03-31pass
statement vs summary · operating cash flowconsolidated 2021-04-01/2022-03-31pass
statement vs summary · operating cash flowconsolidated 2022-04-01/2023-03-31pass
statement vs summary · revenueconsolidated 2021-04-01/2022-03-31pass
statement vs summary · revenueconsolidated 2022-04-01/2023-03-31pass
statement vs summary · revenuenon_consolidated 2021-04-01/2022-03-31pass
statement vs summary · revenuenon_consolidated 2022-04-01/2023-03-31pass
statement vs summary · total assetsconsolidated 2022-03-31pass
statement vs summary · total assetsconsolidated 2023-03-31pass
statement vs summary · total assetsnon_consolidated 2022-03-31pass
statement vs summary · total assetsnon_consolidated 2023-03-31pass